Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000059063 | SCV000322389 | pathogenic | not provided | 2016-03-07 | criteria provided, single submitter | clinical testing | The L28P pathogenic variant has been reported previously in association with APECED (Heino et al., 1999). The variant was not observed in approximately 5,600 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. L28P is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position within the HSR domain that is conserved across species, and the HSR domain is critical for the transcriptional and homodimerization properties of the AIRE protein (Pitkänen et al., 2000). In silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, functional studies have demonstrated that cells transfected with the L28P allele lack expression of mRNA from AIRE-dependent genes, and show incorrect or partial localization of the AIRE protein (Oftedal et al., 2015). |
Invitae | RCV000810303 | SCV000950497 | pathogenic | Polyglandular autoimmune syndrome, type 1 | 2023-09-29 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt AIRE protein function. This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 28 of the AIRE protein (p.Leu28Pro). This variant is present in population databases (rs179363878, gnomAD 0.006%). This missense change has been observed in individual(s) with autoimmune polyendocrinopathy type 1 (APS-1) or autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED) (PMID: 9837820, 9888391, 10946904). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 68229). Experimental studies have shown that this missense change affects AIRE function (PMID: 14974083, 16114041, 26084028, 29335648). For these reasons, this variant has been classified as Pathogenic. |
Ai |
RCV000059063 | SCV002503321 | pathogenic | not provided | 2021-06-23 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000810303 | SCV002810520 | likely pathogenic | Polyglandular autoimmune syndrome, type 1 | 2021-10-04 | criteria provided, single submitter | clinical testing | |
National Institute of Allergy and Infectious Diseases - |
RCV000810303 | SCV004036187 | pathogenic | Polyglandular autoimmune syndrome, type 1 | 2023-09-14 | criteria provided, single submitter | clinical testing | |
Uni |
RCV000059063 | SCV000090584 | not provided | not provided | no assertion provided | not provided |